Anthropic has announced a significant expansion of its AI model Claude into healthcare and life sciences, as competition heats up around medical-focused AI tools. The move comes a few days after ChatGPT launched ChatGPT Health, a dedicated health experience designed to help users manage and understand their medical information.
The AI company said the update builds on its earlier launch of Claude for Life Sciences and introduces a new offering called Claude for Healthcare. This version is designed to help healthcare providers, insurers, startups, researchers, and patients by reducing administrative burden, improving access to information, and expediting processes that can delay patient care and research.
The updates are based on enhancements in Claude Opus 4.5, Anthropic’s latest model. This model is said to improve medical reasoning, calculations, and agent tasks, while also decreasing factual mistakes.
These changes come at a time when healthcare systems are facing challenges like increased workloads, disorganised data, and slow processes.
Tasks such as prior authorisation, claims appeals, and trial documentation can take hours and often require the use of multiple systems.
Here are five things to know about Anthropic’s healthcare and life sciences push.
1. What is Claude for Healthcare actually?
Claude for Healthcare is a suite of tools that enables healthcare providers, payers, startups, and consumers to perform medical tasks via HIPAA-ready products. It is designed for real workflows, not casual advice, and supports administrative, clinical, and operational use cases.
2. Direct connections to medical databases
Claude can now connect to major healthcare systems, including the CMS Coverage Database, ICD-10 codes, the National Provider Identifier Registry, and PubMed. This helps teams quickly find coverage rules, coding information, provider details, and medical research without manual searching.
3. Help with prior authorisation and claims
One of the biggest focuses is prior authorisation. Claude can pull coverage requirements, check them against patient records, and prepare structured reviews for payers. It can also help providers build stronger claims appeals by assembling the right documents and guidelines in one place.
4. Personal health data, with user control
In the US, Claude Pro and Max users can choose to connect lab results and health records through new integrations. Claude can then summarise medical history, explain test results in plain language, and help users prepare for doctor appointments. Users must opt in and can disconnect at any time.
5. Push into clinical trials and regulation
Claude for Life Sciences now extends into clinical trial operations and regulatory work. New connectors allow access to trial data, preprint research, and drug discovery tools. Claude can draft trial protocols, monitor trial performance, and help prepare regulatory submissions using existing guidelines and templates.
Claude is designed to include contextual disclaimers, acknowledge its uncertainty, and direct users to healthcare professionals for personalised guidance.
